Chloroquine: Comprehensive Evidence-Based Product Monograph

Prodotti simili

Elimite

Prezzo da €37.34

Vedi

Fenbendazole

Prezzo da €48.38

Vedi

Eurax

Prezzo da €41.59

Vedi

Hsquin

Prezzo da €36.50

Vedi

Stromectol

Prezzo da €55.17

Vedi

Acticin

Prezzo da €42.44

Vedi

What is Chloroquine? Its Role in Modern Medicine

Look, I’ve been practicing infectious disease medicine for nearly two decades, and chloroquine is one of those drugs that keeps surprising us. Developed in 1934 by Hans Andersag at Bayer, this synthetic quinine derivative has been through more clinical ups and downs than most medications I’ve encountered.

Chloroquine phosphate, the oral formulation most commonly prescribed, belongs to the 4-aminoquinoline class. Its primary claim to fame? Malaria treatment. But here’s where it gets interesting—over the years, we’ve found it works for rheumatoid arthritis, lupus erythematosus, and even some viral infections. The drug’s versatility stems from its unique mechanism, which I’ll get into in a moment.

The standard formulation comes as 250 mg tablets (containing 150 mg base) and 500 mg tablets (300 mg base). Injectable forms exist for severe cases, but honestly, I’ve rarely used those outside of ICU settings.

Key Components and Bioavailability

The active pharmaceutical ingredient is chloroquine phosphate, a white crystalline powder that’s highly soluble in water. What many clinicians don’t appreciate is how variable absorption can be.

Absorption kinetics:

• Oral bioavailability: 89% (range 67-100%)
• Peak plasma concentration: 1-2 hours post-dose
• Volume of distribution: 100-1000 L/kg (massive tissue binding)
• Half-life: 30-60 days (yes, you read that right—weeks)

The drug accumulates extensively in tissues, particularly the liver, spleen, kidneys, and lungs. Erythrocytes concentrate chloroquine at levels 10-20 times higher than plasma. This tissue sequestration explains both the prolonged half-life and the potential for toxicity with repeated dosing.

I remember a case from my residency—a 45-year-old woman with refractory lupus who’d been on chloroquine for six months. She developed retinopathy because her cumulative dose had exceeded safe limits. We hadn’t calculated her actual tissue levels. That mistake taught me to always consider the loading phase.

Mechanism of Action: Scientific Substantiation

Here’s where things get fascinating. Chloroquine works through multiple pathways, which explains its broad therapeutic range.

Antimalarial mechanism: The parasite Plasmodium feeds on hemoglobin within red blood cells. This digestion releases heme, which is toxic to the parasite. Normally, the parasite polymerizes heme into harmless hemozoin. Chloroquine inhibits this polymerization, causing toxic heme accumulation and parasite death. Simple, elegant, and devastatingly effective—until resistance emerged.

Immunomodulatory effects: In autoimmune conditions, chloroquine:

• Inhibits toll-like receptor (TLR) signaling, particularly TLR7 and TLR9
• Reduces pro-inflammatory cytokine production (IL-1, IL-6, TNF-alpha)
• Interferes with antigen presentation by raising endosomal pH
• Suppresses T-cell activation

Antiviral properties: This got huge media attention during COVID-19, but the science predates that. Chloroquine:

• Elevates endosomal pH, preventing viral fusion
• Interferes with glycosylation of viral envelope proteins
• Modulates immune response to viral infection

The antiviral effect is concentration-dependent, which became a major issue during the pandemic. We needed plasma levels that were frankly toxic to achieve significant viral inhibition.

Indications for Use: What is Chloroquine Effective For?

Malaria Treatment and Prophylaxis

This remains the primary indication, though resistance has severely limited its use. In regions without confirmed chloroquine resistance (Central America, parts of the Caribbean, and the Middle East), it remains first-line.

For acute attacks: 600 mg base (1000 mg salt) initially, then 300 mg base at 6, 24, and 48 hours. Total dose: 1500 mg base.

For prophylaxis: 300 mg base once weekly, starting 1-2 weeks before travel and continuing 4 weeks after leaving the endemic area.

Rheumatoid Arthritis

I’ve prescribed this for at least thirty patients over my career. The response is slower than methotrexate—typically 6-12 weeks before improvement—but it’s remarkably well-tolerated in the long term.

Standard dosing: 250 mg daily (150 mg base), not exceeding 4 mg/kg/day.

Discoid and Systemic Lupus Erythematosus

Chloroquine reduces cutaneous manifestations and prevents disease flares. One study from 2018 showed a 40% reduction in flare rates compared to placebo over 12 months.

Dosing: 250-500 mg daily, with careful ophthalmological monitoring.

COVID-19 (Historical Context)

Let me be direct about this. The initial in vitro studies showed promise, but subsequent clinical trials were disappointing. The WHO Solidarity Trial and RECOVERY Trial both showed no mortality benefit. We learned a hard lesson about extrapolating from bench to bedside.

Instructions for Use: Dosage and Course of Administration

Important administration notes:

• Take with food to reduce gastrointestinal irritation
• Do not crush enteric-coated tablets
• Avoid antacids within 4 hours (reduces absorption by 18-50%)
• Monitor for visual changes monthly initially, then quarterly

Contraindications and Drug Interactions

Absolute contraindications:

• Retinopathy or visual field defects
• G6PD deficiency (relative—can cause hemolysis)
• Psoriasis (may exacerbate)
• Porphyria

Pregnancy: The drug crosses the placenta. However, for malaria in pregnancy, the benefits generally outweigh risks. For autoimmune conditions, consider hydroxychloroquine instead.

Drug interactions:

• Cimetidine: increases chloroquine levels by 50%
• Ampicillin: reduced absorption
• Antiepileptics: decreased seizure threshold
• Digoxin: increased digoxin levels
• Hepatotoxic drugs: additive liver toxicity

I had a patient once—a 62-year-old man on chloroquine for RA who developed sudden hearing loss. Turned out he was also taking high-dose aspirin. The combination caused ototoxicity. We discontinued both, and his hearing partially recovered. That case still bothers me.

Clinical Studies and Evidence Base

Let me walk through the key trials that shaped my practice.

Malaria efficacy (World Health Organization data): In areas without resistance, chloroquine achieves 95% cure rates for P. falciparum and 100% for P. vivax. However, resistance emerged in Southeast Asia in the 1950s and has since spread globally.

Rheumatoid arthritis (Clark et al., 1993): A double-blind, placebo-controlled trial of 120 patients showed significant improvement in joint swelling, morning stiffness, and pain scores at 24 weeks. The number needed to treat was 4.5.

Lupus (Canadian Hydroxychloroquine Study Group, 1991): Hydroxychloroquine (a related compound) reduced lupus flares by 57% compared to placebo. Chloroquine shows comparable efficacy.

COVID-19 (RECOVERY Trial, 2020): 11,000 patients randomized. No benefit in mortality, hospital stay, or ventilation requirements. This essentially ended its use for COVID-19.

Comparing Chloroquine with Similar Products

Chloroquine vs. Hydroxychloroquine:

• Hydroxychloroquine has a better safety profile (less retinopathy)
• Chloroquine is more potent (2:1 ratio)
• Hydroxychloroquine preferred for autoimmune conditions
• Chloroquine remains preferred for malaria in sensitive regions

Chloroquine vs. Quinine:

• Quinine causes cinchonism (tinnitus, headache, visual disturbances)
• Chloroquine has better tolerability
• Quinine requires dosing every 8 hours vs. weekly for chloroquine prophylaxis

Chloroquine vs. Artemisinin-based therapies:

• Artemisinins clear parasites faster
• Chloroquine is significantly cheaper
• Artemisinins preferred for resistant malaria

Frequently Asked Questions

What is the recommended course of chloroquine to achieve results?

For malaria, you’ll see improvement within 24-48 hours. For autoimmune conditions, expect 6-12 weeks before noticeable benefit. Don’t give up too early.

Can chloroquine be combined with methotrexate?

Yes, but monitor liver function and blood counts more frequently. The combination can be effective for refractory RA.

How long does chloroquine stay in your system?

The terminal half-life is 30-60 days. Complete elimination takes 2-5 months after discontinuation. This matters for toxicity monitoring.

What are the early signs of retinopathy?

Patients may notice difficulty reading, color vision changes, or central scotomas. Annual eye exams are mandatory for anyone on long-term therapy.

Is chloroquine safe for children?

Yes, but dosing must be weight-based. The pediatric dose for malaria is 10 mg/kg base initially, then 5 mg/kg at 6, 24, and 48 hours.

Validity of Chloroquine Use in Clinical Practice

After twenty years of prescribing this drug, I can tell you it has a definite but narrowing role. The emergence of resistance has limited its antimalarial utility, but its immunomodulatory effects remain valuable.

The risk-benefit calculation depends heavily on indication:

• For chloroquine-sensitive malaria: strongly positive
• For lupus and RA: positive with proper monitoring
• For viral infections: largely negative based on current evidence

My personal practice: I prescribe chloroquine for lupus patients who can’t tolerate hydroxychloroquine, and for malaria prophylaxis in travelers to regions without resistance. I rarely use it for RA anymore—hydroxychloroquine is safer.

The retinopathy risk is real and cumulative. The American Academy of Ophthalmology recommends screening at baseline, then annually after five years of use. The risk exceeds 1% after 5-7 years and 2% after 10-15 years.

A final clinical pearl: Always check G6PD status before prescribing. I learned this the hard way when a 30-year-old African American man developed acute hemolytic anemia after his first dose. His G6PD level was 1.2 U/gHb (normal >4.6). We managed it with supportive care, but it was a close call.

Dr. James Mitchell, MD, FACP Infectious Disease Specialist 20 years of clinical practice

Last updated: November 2024

This monograph reflects current evidence as of the revision date. Clinical practice should always be guided by individual patient factors and local resistance patterns.